Q3 2021 13F Holders as of 30 Sep 2021
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
33.2M
-
Number of holders
-
39
-
Total 13F shares, excl. options
-
11.2M
-
Shares change
-
+200K
-
Total reported value, excl. options
-
$177M
-
Value change
-
+$509K
-
Number of buys
-
17
-
Number of sells
-
-19
-
Price
-
$15.85
Significant Holders of NeuroPace Inc - Common Stock, par value $0.001 per share (NPCE) as of Q3 2021
46 filings reported holding NPCE - NeuroPace Inc - Common Stock, par value $0.001 per share as of Q3 2021.
NeuroPace Inc - Common Stock, par value $0.001 per share (NPCE) has 39 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 11.2M shares
of 33.2M outstanding shares and own 33.67% of the company stock.
Largest 10 shareholders include ORBIMED ADVISORS LLC (4.01M shares), Soleus Capital Management, L.P. (1.67M shares), FMR LLC (1.07M shares), PICTET ASSET MANAGEMENT SA (570K shares), AMERICAN CENTURY COMPANIES INC (517K shares), Bellevue Group AG (508K shares), KORNITZER CAPITAL MANAGEMENT INC /KS (453K shares), Sectoral Asset Management Inc (445K shares), LORD, ABBETT & CO. LLC (359K shares), and BlackRock Inc. (334K shares).
This table shows the top 39 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.